What are my main ‘next decade’ plays on the future? AI: $AMD Banking/Fintech: $SOFI Healthcare: $HIMS I believe all 3 of them will take market share and explode revenue and EPS for the foreseeable future. They don’t even have to become number ones in their respective industries

HIMS, $HIM, CEO is under some social media scrutiny for quote tweeting about a stock squeeze two days ago. Next day, he had a scheduled based on his 10b5-1 plan. The sell appears to take place regularly, with CEO Dudum selling exactly 176,000 shares on several other occasions. $HIMS is down 13% today.

Market reminder: 1st-hour's leaders are in 🔥 📊 AMD, HIMS, APO, SHOP, and APP are climbing the charts, while Nasdaq is at+1.34%. Highlights: 🔹 Apollo $APO rise up as they bid on buying Papa John's $PIZZA. 🔹 Hims and Hers $HIMS is up by 3.61% as they launch a new menopause and perimenopause care service. Time your entry and get started with #Bitget Tokenized Stocks now. 👉 https://t.co/OX1f7w3Kbu

Mark

Today, Novo Nordisk ended partnership with Hims & Hers, $HIMS, over weight loss drug sales. $HIMS dropped 30%.

Hims & Hers, $HIMS, earnings: - Revenue: $586 million, est: $538 million - EPS: $0.2, est: $0.12

Big earnings this week. Today, in after hours: $PLTR, $F, $HIMS and more. Which are you trading? Also we provide full earnings breakdowns and expectations for EVERY STOCK in the market, for free. Check it here:

Hims and Hers, $HIMS, is up nearly 30% today, after Novo Nordisk said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health.

Today the Stock popped +32% at open, contracts hit $10—huge ROI for whoever hit that $HIMS +273% ROI Potential +$500,000 in a week ?

$HIMS: Expecting consolidation here which could take many shapes

Hims & Hers, $HIMS, is down 23% today. It is down 35% on the week.

#Downgrades - Feb 25, 2025 • $AB: TD Cowen Downgrades to Hold from Buy - PT $38.50 (from $38) • $CIVI: KeyBanc Downgrades to Sector Weight from Overweight • $FPI: Lucid Capital Downgrades to Neutral from Buy - PT $12.50 (from $13) • $HIMS: Nephron Downgrades to Hold from Buy - PT $40 • $LILA: Barclays Downgrades to Underweight from Equalweight - PT $6.50 (from $8) • $O: BNP Paribas Downgrades to Neutral from Outperform - PT $61 • $TEM: JPMorgan Downgrades to Neutral from Overweight - PT $55 (from $50)

Him and Hers, $HIMS, earnings: - Revenue: $481 million, est: $470 million - EPS: $0.11, est: $0.1

$HIMS is up 20%.

Hims & Hers, $HIMS, to offer at-home blood draws and lab testing

Video review of strong stock setups +#BTC/Gold LTF $WGMI/BTC, $TSLA, $CELH, $ARKK, $ARKG, $BABA $UPST, $HIMS Enjoy

$HIMS: Looking for some consolidation of this last move in the form of a possible diagonal

$HIMS: Consolidating above ATH after an impulsive move= very bullish posture. Could take a few weeks to resolve but ultimately I think it moves higher

They told me $sofi and $hims are next $pltr But I don’t have enough money ☹️